WEDNESDAY, Dec. 22, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved the emergency use of Pfizer’s new antiviral pill Paxlovid in people who are at high risk for severe COVID-19. It’s the first approved treatment for COVID-19 meant to be taken at home. “Today’s authorizationContinue Reading

WEDNESDAY, Dec. 22, 2021 (HealthDay News) — The U.S. Army says it has developed a COVID-19 vaccine it believes could work against any and all coronavirus variants, including Omicron. Results from early human trials of the Spike Ferritin Nanoparticle (SpFN) COVID vaccine are expected by the end of the month,Continue Reading

WEDNESDAY, Dec. 22, 2021 (HealthDay News) — They may have other proven health benefits, but new research shows that fish oil supplements don’t prevent depression or improve mood. Some experts recommend omega-3 fish oil supplements to help prevent depression in high-risk patients, but studies have yielded mixed results and thereContinue Reading

TUESDAY, Dec. 21, 2021 (HealthDay News) — Far from terrorizing people as they did in “Jaws,” sharks may offer humanity hope in fending off future coronavirus outbreaks, new research suggests. That’s because their immune systems have unique antibody-like proteins called VNARs that can prevent the SARS-COV-2 virus that causes COVID-19Continue Reading

FRIDAY, Dec. 17, 2021 (HealthDay News) — Two doses of a pediatric Pfizer-BioNTech COVID-19 vaccine failed to spur an adequate immune response in children aged 2 to 5, the companies announced Friday. That’s a setback for parents hoping to get their youngest children immunized against the new coronavirus as soonContinue Reading

FRIDAY, Dec. 17, 2021 (HealthDay News) — Recovery from heart surgery can bring some pain. But a new study suggests patients don’t need potentially addictive prescription opioids to control that post-op discomfort. “This study shows that discharge without opioid pain medicine after cardiac surgery is extremely well tolerated by someContinue Reading

TUESDAY, Dec. 14, 2021 (HealthDay News) — For certain leukemia patients, some welcome findings: New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy. The study involved 85 patients with chronic lymphocytic leukemia (CLL). All were 65 or younger, and 46 had more aggressive, unmutated IGHV subtypeContinue Reading